DE3275903D1 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
DE3275903D1
DE3275903D1 DE8282100354T DE3275903T DE3275903D1 DE 3275903 D1 DE3275903 D1 DE 3275903D1 DE 8282100354 T DE8282100354 T DE 8282100354T DE 3275903 T DE3275903 T DE 3275903T DE 3275903 D1 DE3275903 D1 DE 3275903D1
Authority
DE
Germany
Prior art keywords
etintidine
pharmaceutical compositions
concomitant administration
pepstatin
pepsin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282100354T
Other languages
German (de)
English (en)
Inventor
Joseph P Buyniski
Robert L Cavanagh
Maxwell Gordon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Application granted granted Critical
Publication of DE3275903D1 publication Critical patent/DE3275903D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8282100354T 1981-01-19 1982-01-19 Pharmaceutical compositions Expired DE3275903D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/225,945 US4339439A (en) 1981-01-19 1981-01-19 Pharmaceutical methods and compositions

Publications (1)

Publication Number Publication Date
DE3275903D1 true DE3275903D1 (en) 1987-05-07

Family

ID=22846923

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282100354T Expired DE3275903D1 (en) 1981-01-19 1982-01-19 Pharmaceutical compositions

Country Status (9)

Country Link
US (1) US4339439A (OSRAM)
EP (1) EP0056973B1 (OSRAM)
JP (1) JPS57139018A (OSRAM)
AT (1) ATE26214T1 (OSRAM)
CA (1) CA1199872A (OSRAM)
DE (1) DE3275903D1 (OSRAM)
DK (1) DK16282A (OSRAM)
FI (1) FI820136A7 (OSRAM)
GR (1) GR75141B (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI832520A7 (fi) * 1982-07-12 1984-01-13 Bristol Myers Co Farmaseuttisia menetelmiä ja koostumuksia.
US5833946A (en) * 1995-06-06 1998-11-10 Bayer Corporation Dissemination of fungal infections: animal model and method of prophylaxis
WO2020130205A1 (ko) * 2018-12-21 2020-06-25 경상대학교병원 펩신 억제제를 포함하는 약학적 조성물 및 건강기능식품
IT202000012370A1 (it) * 2020-05-26 2021-11-26 Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L Composizione comprendente pepstatina e acido alginico o un suo sale e suo uso

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4101650A (en) * 1977-04-06 1978-07-18 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Pepstatin floating minicapsules
NZ187376A (en) * 1977-06-03 1981-05-29 Bristol Myers Co N-cyano-n-(2-(4-methyl-5-imidazolyl)methylthio)ethyl)-n-alkynyl guanidines intermediates pharmaceutical compositions
US4112234A (en) * 1977-08-22 1978-09-05 Bristol-Myers Company Imidazolylmethylthioethyl alkynyl guanidines

Also Published As

Publication number Publication date
CA1199872A (en) 1986-01-28
FI820136L (fi) 1982-07-20
DK16282A (da) 1982-07-20
JPH0250883B2 (OSRAM) 1990-11-05
FI820136A7 (fi) 1982-07-20
JPS57139018A (en) 1982-08-27
ATE26214T1 (de) 1987-04-15
EP0056973B1 (en) 1987-04-01
GR75141B (OSRAM) 1984-07-13
US4339439A (en) 1982-07-13
EP0056973A1 (en) 1982-08-04

Similar Documents

Publication Publication Date Title
ES8606289A1 (es) Un procedimiento para la preparacion de piridazinaminas.
BG43866A3 (en) Method for preparing of derivatives of 2, 2'- imino- bis- ethanol
SE8504969D0 (sv) A method of making a food composition containing inositoltriphosphate and the composition
NL192564B (nl) Inrichting voor het toedienen van medicamenten aan patiënten.
GR76810B (OSRAM)
MY103536A (en) New use of 5 ht-3 antagonists
JPS5583711A (en) Serum globulin for stabilized immunity
ES525156A0 (es) "procedimiento de extraccion liquidonliquido del galio contenido en soluciones acuosas basicas"
ES525155A0 (es) "procedimiento de extraccion liquidonliquido del galio contenido en soluciones acuosas basicas"
DE3380763D1 (en) Pharmaceutical compositions
GR75141B (OSRAM)
MY100486A (en) Compositions comprising pepstatin and histamine h2-receptor antagonist having an enhanced antiulcer activity
NL186258C (nl) Werkwijze voor de bereiding van cokes, in het bijzonder naaldcokes.
EP0093497A3 (en) Anthelmintic treatment
NL194153B (nl) Preparaat bestemd voor de profylaxe of behandeling van protozoÙninfecties bij dieren.
IT8421820A0 (it) Preparazione del 3,3,3-trifluoro-2-trifluorometilpro pene.
SE8800461L (sv) Farmaceutisk komposition
JPS55113721A (en) Immunity regulator
FI812469A7 (fi) (R.S) -fluorimetyylihistidiinin ja simetidiinin synergistinen yhdistelmä haavaumaa estävänä aineena.
DE3484155D1 (de) Fr-900216-verbindung, durch kultivierung von atcc 20577 gewonnen, als aktive therapeutische verbindung genutzt, und sie enthaltende antitumorale pharmazeutische zusammensetzung von fr-900216.
IT8348067A0 (it) Cianoguanidine, procedimento per ottenerle e composizioni farmaceutiche che le contengono
ES8700940A1 (es) Procedimiento de obtencion de composiciones para el trata- miento de infecciones por rinovirus
NL187583C (nl) Werkwijze voor de bereiding van superbasische oppervlakte-aktieve stoffen voor smeermiddelsamenstellingen.
DE3270466D1 (en) Pharmaceutical composition
DE3262592D1 (en) Guanidinopyrimidines

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee